top of page
Search


Unpacking Trump’s healthcare regulatory agenda: Our predictions for rulemaking in the new administration
Yesterday, Donald Trump was sworn in as President, marking only the second time in U.S. history that a president will serve two...

Kirsta Hackmeier
Jan 219 min read


Key company profiles: Cencora's approach to vertical integration
Today's post is the third in an ongoing series we're publishing on key players in healthcare vertical integration . Nearly everyone in...

Yulan Egan
Jan 167 min read


Employer healthcare spending in 2025: Why it's likely to accelerate
Although the share of Americans with employer-sponsored insurance has been declining for the past couple of decades, the majority of the...

Yulan Egan
Jan 69 min read


What could Make America Healthy Again mean?
Last year at this time, we enjoyed reading Dan Diamond's piece for the Washington Post on how reversing the recent decline in U.S....

Amanda Berra
Dec 18, 202411 min read


'Repeal and Replace' or 'Refine and Reform'? What a second Trump administration could mean for the ACA
In the early days of the first Trump administration—during which the GOP also held control of both Houses of Congress—'Repeal and...

Yulan Egan
Dec 4, 20247 min read


Key company profiles: CVS Health's approach to vertical integration
Today's post is the second in an ongoing series we're publishing on key players in healthcare vertical integration . Nearly everyone in...

Yulan Egan
Nov 19, 20248 min read


Trump's health policy agenda: Eight issues we expect to see (and two we don't)
Earlier this week, former President Trump secured a decisive victory over Vice President Kamala Harris in the race for the White House....

Yulan Egan
Nov 7, 20248 min read


Key company profiles: UnitedHealth Group's approach to vertical consolidation
Today's post is the first of a new series we're launching on key players in healthcare vertical consolidation . And that's because nearly...

Yulan Egan
Sep 10, 20247 min read


The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024
A full 6% of US adults are taking GLP-1s. In this post, we break down what we do—and don't—know about these medications as of August 2024.

Yulan Egan
Aug 21, 20246 min read


Unpacking Disparities in Women’s Healthcare
We’ve spoken in the past about the rise of “femtech” in recent years, as investors rush to fund start-ups specifically catering to...

Kirsta Hackmeier
Aug 1, 20246 min read


Preview "The State of Healthcare 2024"
Here at Union, our annually-updated State of Healthcare is the foundation upon which nearly all of our research builds. We know that in...

Yulan Egan
Jul 24, 20247 min read


How to speak comparative international healthcare
Ever have occasion to talk to partners overseas? Ever been drawn into wonky and/or political discussions comparing U.S. healthcare...

Amanda Berra
Jun 27, 20248 min read
Join our mailing list
Get access to our latest posts
bottom of page